Your browser doesn't support javascript.
loading
iRGD-liposomes enhance tumor delivery and therapeutic efficacy of antisense oligonucleotide drugs against primary prostate cancer and bone metastasis.
Guan, Jibin; Guo, Hong; Tang, Tang; Wang, Yihan; Wei, Yushuang; Seth, Punit; Li, Yingming; Dehm, Scott M; Ruoslahti, Erkki; Pang, Hong-Bo.
  • Guan J; Department of Pharmaceutics, School of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
  • Guo H; Department of Pharmaceutics, School of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
  • Tang T; Department of Pharmaceutics, School of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
  • Wang Y; Department of Pharmaceutics, School of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
  • Wei Y; Department of Pharmaceutics, School of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
  • Seth P; Ionis Pharmaceuticals, Inc. Carlsbad, CA 92010, United States.
  • Li Y; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States.
  • Dehm SM; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States.
  • Ruoslahti E; Departments of Laboratory Medicine and Pathology and Urology, University of Minnesota, Minneapolis, MN 55455, United States.
  • Pang HB; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, United States.
Adv Funct Mater ; 31(24)2021 Jun 09.
Article en En | MEDLINE | ID: mdl-34211360